Agilent RapidFire/MS Cytochrome P450 Inhibition Application Note

This document introduces the application of Agilent RapidFire/MS systems for high-throughput in vitro ADME analysis, with a focus on cytochrome P450 (CYP) inhibition. The system combines high-throughput sample processing with triple quadrupole (QQQ) or time-of-flight (TOF) mass spectrometry (MS) to streamline ADME assay analysis.

Brand: Agilent
Category: Other
Document type: Application Note
Language: English
Pages: 4
File format: PDF
File size: 214 KB
Published: 11 June, 2012
Updated: 28 September, 2023
Model: P450
MD5 checksum: 0AB2D4F3B3A74F8AE91059427D9CA234
PDF: Agilent RapidFire/MS Cytochrome P450 Inhibition Application Note PDF

About this manual

This document details the application of Agilent RapidFire/MS systems for analyzing cytochrome P450 (CYP) inhibition, a critical step in drug discovery to prevent adverse drug-drug interactions. The note explains how these systems streamline the evaluation of a large number of samples efficiently.

What's inside

Direct Cytochrome P450 Inhibition
Time-Dependent Cytochrome P450 Inhibition
FDA Recommended Drug Probes
Comparison with LC/MS/MS
RapidFire/MS Systems
Cytochrome P450 Assays
High-Throughput Analysis
Drug Discovery Process

Specifications

Run time per sample	approximately 6 s
Comparison run time	2-4 min
Throughput increase	greater than 10-fold
Productivity increase	approximately 20-fold

Frequently asked questions

What are the FDA recommended drug probes for CYP3A4/5?

The FDA recommended drug probes for CYP3A4/5 are midazolam, testosterone, nifedipine, and erythromycin.

Does the RapidFire system produce equivalent results to LC/MS/MS?

Yes, the RapidFire system produces equivalent results to LC/MS/MS for CYP inhibition assays.

Download PDF (214 KB)